Accolade ACCD Stock
Accolade Price Chart
Accolade ACCD Financial and Trading Overview
| Accolade stock price | 7.03 USD |
| Previous Close | 13.78 USD |
| Open | 13.67 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 13.27 - 14.15 USD |
| 52 Week Range | 5.45 - 17.01 USD |
| Volume | 393.67K USD |
| Avg. Volume | 614.25K USD |
| Market Cap | 1.02B USD |
| Beta (5Y Monthly) | 1.693512 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.28 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.53 USD |
ACCD Valuation Measures
| Enterprise Value | 1.01B USD |
| Trailing P/E | N/A |
| Forward P/E | -8.796178 |
| PEG Ratio (5 yr expected) | 8.82 |
| Price/Sales (ttm) | 2.8002422 |
| Price/Book (mrq) | 2.1305153 |
| Enterprise Value/Revenue | 2.79 |
| Enterprise Value/EBITDA | -9.182 |
Trading Information
Accolade Stock Price History
| Beta (5Y Monthly) | 1.693512 |
| 52-Week Change | 141.01% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 17.01 USD |
| 52 Week Low | 5.45 USD |
| 50-Day Moving Average | 12.97 USD |
| 200-Day Moving Average | 11.23 USD |
ACCD Share Statistics
| Avg. Volume (3 month) | 614.25K USD |
| Avg. Daily Volume (10-Days) | 454.44K USD |
| Shares Outstanding | 73.63M |
| Float | 71.68M |
| Short Ratio | 4.92 |
| % Held by Insiders | 2.03% |
| % Held by Institutions | 82.29% |
| Shares Short | 3.38M |
| Short % of Float | 4.66% |
| Short % of Shares Outstanding | 4.59% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | February 28, 2023 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | February 28, 2024 |
Profitability
| Profit Margin | -126.57% |
| Operating Margin (ttm) | -42.82% |
| Gross Margin | 45.50% |
| EBITDA Margin | -30.38% |
Management Effectiveness
| Return on Assets (ttm) | -8.88% |
| Return on Equity (ttm) | -69.14% |
Income Statement
| Revenue (ttm) | 363.14M USD |
| Revenue Per Share (ttm) | 5.1 USD |
| Quarterly Revenue Growth (yoy) | 5.60% |
| Gross Profit (ttm) | 165.26M USD |
| EBITDA | -110345000 USD |
| Net Income Avi to Common (ttm) | -459649984 USD |
| Diluted EPS (ttm) | -6.59 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 321.08M USD |
| Total Cash Per Share (mrq) | 4.36 USD |
| Total Debt (mrq) | 317.39M USD |
| Total Debt/Equity (mrq) | 66.99 USD |
| Current Ratio (mrq) | 3.065 |
| Book Value Per Share (mrq) | 6.482 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -40705000 USD |
| Levered Free Cash Flow (ttm) | 21.61M USD |
Profile of Accolade
| Country | United States |
| State | WA |
| City | Seattle |
| Address | 1201 Third Avenue |
| ZIP | 98101 |
| Phone | 206 926 8100 |
| Website | https://www.accolade.com |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 2370 |
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.
Q&A For Accolade Stock
What is a current ACCD stock price?
Accolade ACCD stock price today per share is 7.03 USD.
How to purchase Accolade stock?
You can buy ACCD shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Accolade?
The stock symbol or ticker of Accolade is ACCD.
Which industry does the Accolade company belong to?
The Accolade industry is Health Information Services.
How many shares does Accolade have in circulation?
The max supply of Accolade shares is 81.99M.
What is Accolade Price to Earnings Ratio (PE Ratio)?
Accolade PE Ratio is now.
What was Accolade earnings per share over the trailing 12 months (TTM)?
Accolade EPS is -2.28 USD over the trailing 12 months.
Which sector does the Accolade company belong to?
The Accolade sector is Healthcare.
Accolade ACCD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ Global Select Market Com NQGS | 7625.89 USD — |
-5.84
|
— — | 7621.56 USD — | 7894.21 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}